| P50 | author | Bruce R Schackman | Q90916815 |
| | Lisa R Metsch | Q104982085 |
| | Shiela M Strauss | Q43086340 |
| P2093 | author name string | David C Perlman | |
| | Diana Hernandez | |
| | Daniel J Feaster | |
| | Jemima A Frimpong | |
| | Thomas D'Aunno | |
| | Alissa Mallow | |
| P2860 | cites work | Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C | Q22305322 |
| | Self-reported hepatitis C virus antibody status and risk behavior in young injectors | Q27478003 |
| | Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 |
| | Social networks shape the transmission dynamics of hepatitis C virus | Q28474639 |
| | Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs | Q28479216 |
| | Diffusion of innovations in service organizations: systematic review and recommendations | Q29619132 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis | Q30406126 |
| | Revised guidelines for HIV counseling, testing, and referral | Q34102755 |
| | Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings | Q34567572 |
| | Perceived serosorting of injection paraphernalia sharing networks among injection drug users in Baltimore, MD. | Q34567931 |
| | Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States | Q35008495 |
| | Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment | Q35074748 |
| | Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study | Q35154639 |
| | The urgency of providing comprehensive and integrated treatment for substance abusers with HIV | Q35308404 |
| | Integration of treatment innovation planning and implementation: strategic process models and organizational challenges | Q35680106 |
| | CDC and progress toward integration of HIV, STD, and viral hepatitis prevention | Q35697023 |
| | Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health | Q35697034 |
| | Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs | Q35836781 |
| | Non-injection drug use and Hepatitis C Virus: a systematic review | Q35844048 |
| | Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? | Q35866175 |
| | Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II | Q80733782 |
| | The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions | Q80775844 |
| | A practical approach to developing cases for standardized patients | Q81251750 |
| | Application of ADAPT-ITT: adapting an evidence-based HIV prevention intervention for incarcerated African American adolescent females | Q84271059 |
| | Missed opportunities for hepatitis C testing in opioid treatment programs | Q86617180 |
| | Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study | Q87870147 |
| | Moving evidence-based drug abuse prevention programs from basic science to practice: "bridging the efficacy-effectiveness interface". | Q35978388 |
| | Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008 | Q36100389 |
| | Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs | Q36129595 |
| | Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV. | Q36304433 |
| | Brief cognitive behavioral therapy in primary care: a hybrid type 2 patient-randomized effectiveness-implementation design | Q36416486 |
| | Rapid HIV testing: a review of the literature and implications for the clinician | Q36619812 |
| | HIV rapid testing in drug treatment: comparison across treatment modalities. | Q36625328 |
| | Characteristics of adults with substance use disorders expected to be eligible for Medicaid under the ACA. | Q36901860 |
| | The importance of social networks in their association to drug equipment sharing among injection drug users: a review | Q36970706 |
| | The challenge of hepatitis C in the HIV-infected person | Q37054403 |
| | Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact | Q37063730 |
| | Sexual behavior and STI/HIV status among adolescents in rural Malawi: an evaluation of the effect of interview mode on reporting | Q37161403 |
| | HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations | Q37339543 |
| | Viral hepatitis and HIV co-infection | Q37626908 |
| | Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. | Q37708287 |
| | Hepatitis C virus therapy update 2013. | Q38096913 |
| | Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units | Q38459007 |
| | Social network characteristics and injecting HIV-risk behaviors among street injection drug users | Q39453045 |
| | Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States | Q40786866 |
| | HIV testing updates and challenges: when regulatory caution and public health imperatives collide | Q41500321 |
| | Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs | Q41632410 |
| | HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates | Q41963218 |
| | The dynamics of injection drug users' personal networks and HIV risk behaviors | Q42688282 |
| | Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research | Q42690103 |
| | Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. | Q42978282 |
| | Design of a faith-based HIV intervention: successful collaboration between a university and a church | Q43966767 |
| | The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 |
| | Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care | Q45305778 |
| | Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus | Q45364058 |
| | Failure to return for HIV test results: a pilot study of three community testing sites | Q46196669 |
| | Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention | Q46424020 |
| | Gaps in the drug-free and methadone treatment program response to Hepatitis C. | Q47754839 |
| | Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. | Q50169211 |
| | Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations. | Q51778568 |
| | A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. | Q51867806 |
| | Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. | Q52092099 |
| | Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. | Q55169026 |
| | Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users | Q61098957 |
| | Assessment of clinical competence using an objective structured clinical examination (OSCE) | Q67470832 |
| | Providing medical care to methadone clinic patients: referral vs on-site care | Q72747152 |
| P433 | issue | 1 | |
| P921 | main subject | substance use disorder | Q7632070 |
| | study protocol | Q111908491 |
| P304 | page(s) | 117 | |
| P577 | publication date | 2016-03-03 | |
| P1433 | published in | Trials | Q7840023 |
| P1476 | title | On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial | |
| P478 | volume | 17 | |